mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |